Literature DB >> 6087971

Treatment of advanced carcinoma of the prostate.

G Williams, S R Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6087971      PMCID： PMC1442837          DOI： 10.1136/bmj.289.6445.571

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  16 in total

1.  Temporary employment in the NHS.

Authors:  J V Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

2.  Endocrine control of prostatic carcinoma; clinical and statistical survey of 1,818 cases.

Authors:  R M NESBIT; W C BAUM
Journal:  J Am Med Assoc       Date:  1950-08-12

3.  Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

Authors:  D Kerle; G Williams; H Ware; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-25

4.  Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.

Authors:  J M Allen; J P O'Shea; K Mashiter; G Williams; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-21

5.  Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer.

Authors:  J M Allen; D J Kerle; H Ware; A Doble; G Williams; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

6.  Role of lymphography in carcinoma of the prostate.

Authors:  R M Paxton; G Williams; J S Macdonald
Journal:  Br Med J       Date:  1975-01-18

7.  Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors:  G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  The clinical spectrum of prostate cancer.

Authors:  R de Vere White; D F Paulson; J F Glenn
Journal:  J Urol       Date:  1977-03       Impact factor: 7.450

9.  Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma.

Authors:  K J Walker; R I Nicholson; A O Turkes; A Turkes; K Griffiths; M Robinson; Z Crispin; S Dris
Journal:  Lancet       Date:  1983-08-20       Impact factor: 79.321

10.  Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.

Authors:  J H Waxman; J A Wass; W F Hendry; H N Whitfield; G M Besser; J S Malpas; R T Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-23
View more
  1 in total

Review 1.  Combination therapy in stage C and D prostatic cancer: rationale and five year clinical experience.

Authors:  F Labrie; A Dupont; A Bélanger; L Cusan; M Giguère; Y Lacourcière; I Luthy; D Bégin; C Labrie; J Simard
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.